CRT-D is the supported therapy choice for patients in NYHA class III/IV with an LVEF of 35%, QRS width of 120 ms, and a conventional indication for an ICD.
Does CRT-D provide benefit in patients in NYHA class III/IV, with LVEF of 35%, QRS width of 120 ms with a conventional indication for an ICD?
The 2010 ESC Guidelines support the use of CRT-D in patients with NYHA class III/IV, LVEF of 35%, QRS width of 120 ms, and a conventional indication for an ICD.
One large study, MIRACLE ICD 9 and one large meta-analysis 15 support the choice of a CRT-D in patients in NYHA class III/IV, with LVEF of 35%, QRS width of 120 ms with a conventional indication for an ICD.
Members et al. (2010) studied this question. CRT-D is the supported therapy choice for patients in NYHA class III/IV with an LVEF of 35%, QRS width of 120 ms, and a conventional indication for an ICD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: